138 related articles for article (PubMed ID: 7093981)
1. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
[TBL] [Abstract][Full Text] [Related]
2. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
Magliulo E; Bonizzoni D; Cattaneo E; Scevola D; Concia E
Minerva Med; 1975 Apr; 66(25):1187-97. PubMed ID: 1134660
[No Abstract] [Full Text] [Related]
3. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
Braga PC; Bossi R; Allegra L
Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of Sobrerol in chronic bronchitis. Comparison of serum and bronchial mucus levels.
Braga PC; De Angelis L; Bossi R; Scaglione F; Scarpazza G; Allegra L; Fraschini F
Eur J Clin Pharmacol; 1983; 24(2):209-15. PubMed ID: 6840169
[TBL] [Abstract][Full Text] [Related]
5. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
Goodman RM; Yergin BM; Sackner MA
Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
[TBL] [Abstract][Full Text] [Related]
6. Comparison between penetration of amoxicillin combined with carbocysteine and amoxicillin alone in pathological bronchial secretions and pulmonary tissue.
Braga PC; Scaglione F; Scarpazza G; Fraticelli G; Roviaro G; Varoli F; Mariani C; Falchi M; Fraschini F
Int J Clin Pharmacol Res; 1985; 5(5):331-40. PubMed ID: 4066083
[TBL] [Abstract][Full Text] [Related]
7. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
Allegra L; Cordaro CI; Grassi C
Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
[TBL] [Abstract][Full Text] [Related]
8. S-carboxymethylcysteine in the fluidification of sputum and treatment of chronic airway obstruction.
Edwards GF; Steel AE; Scott JK; Jordan JW
Chest; 1976 Oct; 70(4):506-13. PubMed ID: 789027
[TBL] [Abstract][Full Text] [Related]
9. No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
Thomson ML; Pavia D; Jones CJ; McQuiston TA
Thorax; 1975 Dec; 30(6):669-73. PubMed ID: 769242
[TBL] [Abstract][Full Text] [Related]
10. Effect of S-carboxymethylcysteine lysine salt on mucociliary clearance in rabbits with secretory cell metaplasia.
Daffonchio L; De Santi MM; Gardi C; Lungarella G; Omini C
Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):59-74. PubMed ID: 7850257
[TBL] [Abstract][Full Text] [Related]
11. [Changes in sputum in catarrhal bronchitis in children after treatment with S-carboxymethylcysteine (viscosimetric studies)].
Castello D; Costa G; De Candussio G
Minerva Pediatr; 1979 Mar; 31(5):371-80. PubMed ID: 460097
[No Abstract] [Full Text] [Related]
12. Effect of S-carboxymethylcysteine on the biophysical and biochemical properties of mucus in chronic bronchitics.
Cox A; Jabbal-Gill I; Marriott C; Davis SS
Adv Exp Med Biol; 1982; 144():423-9. PubMed ID: 7080939
[No Abstract] [Full Text] [Related]
13. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.
Livingstone CR; Andrews MA; Jenkins SM; Marriott C
J Pharm Pharmacol; 1990 Feb; 42(2):73-8. PubMed ID: 1972405
[TBL] [Abstract][Full Text] [Related]
14. [Optimal use of expectorants (current trends)].
Mirrakhimov MM; Brimkulov NN; Rafibekova ZhS
Ter Arkh; 1981; 53(1):110-7. PubMed ID: 7013137
[No Abstract] [Full Text] [Related]
15. [Serum and bronchial concentrations of amoxicillin administered with a bronchial fluidizer].
Concia E; Dos Santos C; Marone P; Sardi C; Cremaschi P
Boll Ist Sieroter Milan; 1982 Mar; 61(1):64-70. PubMed ID: 7126331
[TBL] [Abstract][Full Text] [Related]
16. [Absorption, elimination and therapeutic effectiveness of a new antibiotic and mucolytic combination for oral administration].
Silvia G; Giambrone F; Battaglia E; Romano M
G Clin Med; 1981 Mar; 62(3):209-27. PubMed ID: 7250579
[No Abstract] [Full Text] [Related]
17. [Mucodine in the treatment of chronic bronchitis].
Wierzbicka M; Wójcik RA
Pneumonol Pol; 1981; 49(5):369-76. PubMed ID: 7022385
[No Abstract] [Full Text] [Related]
18. Lack of gastric effects of S-(carboxy-methyl)-L-cysteine.
Domschke W; Domschke S; Demling L
Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):213-5. PubMed ID: 941624
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis.
Braga PC; Allegra L; Rampoldi C; Ornaghi A; Beghi G
Respiration; 1990; 57(6):353-8. PubMed ID: 2099568
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
Solopov VN; Kolganova NA
Sov Med; 1988; (5):69-72. PubMed ID: 3062806
[No Abstract] [Full Text] [Related]
[Next] [New Search]
